Robert J. Davie
Chief Executive Officer at Pharm-Olam International Ltd.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Natalie Kay Gassen | F | 49 |
Pharm-Olam Group Ltd.
Pharm-Olam Group Ltd. Miscellaneous Commercial ServicesCommercial Services Part of CATO SMS, Pharm-Olam Group Ltd. is a clinical research organization that specializes in government-funded research. Based in Bracknell, UK, Pharm-Olam Group helps small and mid-sized biopharma companies bring new therapies to light by solving distinct challenges. The British company's Resource Center offers the latest articles, blogs, brochures, and videos from their experts. Founded in 2002, the company provides clinical expertise to ensure the success of their clients' products.
Pharm-Olam International Ltd.
Pharm-Olam International Ltd. Miscellaneous Commercial ServicesCommercial Services Pharm-Olam International started operations in 1994 with the premise of delivering cost effective, quick-to-market clinical services in the emerging markets of Central and Eastern Europe. Since then, POI has expanded its services to more than 40 countries, including: North America, Western Europe, Central & Eastern Europe, Latin America, India, and South Africa. Today, POI has one of the largest global footprints of any CRO. They are committed to establishing and maintaining the industry's strongest multi-national presence. Its monitors have the most extensive knowledge of local and regional customs and sites across a broad range of therapeutic areas. POI has an entirely different model than other CROs- they call it global decentralization. The success of this model has been proven time and again. | - |
Zev Munk | M | - |
Pharm-Olam International Ltd.
Pharm-Olam International Ltd. Miscellaneous Commercial ServicesCommercial Services Pharm-Olam International started operations in 1994 with the premise of delivering cost effective, quick-to-market clinical services in the emerging markets of Central and Eastern Europe. Since then, POI has expanded its services to more than 40 countries, including: North America, Western Europe, Central & Eastern Europe, Latin America, India, and South Africa. Today, POI has one of the largest global footprints of any CRO. They are committed to establishing and maintaining the industry's strongest multi-national presence. Its monitors have the most extensive knowledge of local and regional customs and sites across a broad range of therapeutic areas. POI has an entirely different model than other CROs- they call it global decentralization. The success of this model has been proven time and again. | 30 years |
David Grange | M | 76 |
Pharm-Olam International Ltd.
Pharm-Olam International Ltd. Miscellaneous Commercial ServicesCommercial Services Pharm-Olam International started operations in 1994 with the premise of delivering cost effective, quick-to-market clinical services in the emerging markets of Central and Eastern Europe. Since then, POI has expanded its services to more than 40 countries, including: North America, Western Europe, Central & Eastern Europe, Latin America, India, and South Africa. Today, POI has one of the largest global footprints of any CRO. They are committed to establishing and maintaining the industry's strongest multi-national presence. Its monitors have the most extensive knowledge of local and regional customs and sites across a broad range of therapeutic areas. POI has an entirely different model than other CROs- they call it global decentralization. The success of this model has been proven time and again. | 7 years |
James William Clark | M | 72 |
Pharm-Olam International Ltd.
Pharm-Olam International Ltd. Miscellaneous Commercial ServicesCommercial Services Pharm-Olam International started operations in 1994 with the premise of delivering cost effective, quick-to-market clinical services in the emerging markets of Central and Eastern Europe. Since then, POI has expanded its services to more than 40 countries, including: North America, Western Europe, Central & Eastern Europe, Latin America, India, and South Africa. Today, POI has one of the largest global footprints of any CRO. They are committed to establishing and maintaining the industry's strongest multi-national presence. Its monitors have the most extensive knowledge of local and regional customs and sites across a broad range of therapeutic areas. POI has an entirely different model than other CROs- they call it global decentralization. The success of this model has been proven time and again. | - |
Eugene Barg | M | - |
Pharm-Olam International Ltd.
Pharm-Olam International Ltd. Miscellaneous Commercial ServicesCommercial Services Pharm-Olam International started operations in 1994 with the premise of delivering cost effective, quick-to-market clinical services in the emerging markets of Central and Eastern Europe. Since then, POI has expanded its services to more than 40 countries, including: North America, Western Europe, Central & Eastern Europe, Latin America, India, and South Africa. Today, POI has one of the largest global footprints of any CRO. They are committed to establishing and maintaining the industry's strongest multi-national presence. Its monitors have the most extensive knowledge of local and regional customs and sites across a broad range of therapeutic areas. POI has an entirely different model than other CROs- they call it global decentralization. The success of this model has been proven time and again. | 30 years |
Julia Graz | F | - |
Pharm-Olam International Ltd.
Pharm-Olam International Ltd. Miscellaneous Commercial ServicesCommercial Services Pharm-Olam International started operations in 1994 with the premise of delivering cost effective, quick-to-market clinical services in the emerging markets of Central and Eastern Europe. Since then, POI has expanded its services to more than 40 countries, including: North America, Western Europe, Central & Eastern Europe, Latin America, India, and South Africa. Today, POI has one of the largest global footprints of any CRO. They are committed to establishing and maintaining the industry's strongest multi-national presence. Its monitors have the most extensive knowledge of local and regional customs and sites across a broad range of therapeutic areas. POI has an entirely different model than other CROs- they call it global decentralization. The success of this model has been proven time and again. | - |
Miguel Salcedo | M | - |
Pharm-Olam International Ltd.
Pharm-Olam International Ltd. Miscellaneous Commercial ServicesCommercial Services Pharm-Olam International started operations in 1994 with the premise of delivering cost effective, quick-to-market clinical services in the emerging markets of Central and Eastern Europe. Since then, POI has expanded its services to more than 40 countries, including: North America, Western Europe, Central & Eastern Europe, Latin America, India, and South Africa. Today, POI has one of the largest global footprints of any CRO. They are committed to establishing and maintaining the industry's strongest multi-national presence. Its monitors have the most extensive knowledge of local and regional customs and sites across a broad range of therapeutic areas. POI has an entirely different model than other CROs- they call it global decentralization. The success of this model has been proven time and again. | - |
Tricia Bland | F | - |
Pharm-Olam International Ltd.
Pharm-Olam International Ltd. Miscellaneous Commercial ServicesCommercial Services Pharm-Olam International started operations in 1994 with the premise of delivering cost effective, quick-to-market clinical services in the emerging markets of Central and Eastern Europe. Since then, POI has expanded its services to more than 40 countries, including: North America, Western Europe, Central & Eastern Europe, Latin America, India, and South Africa. Today, POI has one of the largest global footprints of any CRO. They are committed to establishing and maintaining the industry's strongest multi-national presence. Its monitors have the most extensive knowledge of local and regional customs and sites across a broad range of therapeutic areas. POI has an entirely different model than other CROs- they call it global decentralization. The success of this model has been proven time and again. | - |
Mark Eberhardt | M | - |
Pharm-Olam International Ltd.
Pharm-Olam International Ltd. Miscellaneous Commercial ServicesCommercial Services Pharm-Olam International started operations in 1994 with the premise of delivering cost effective, quick-to-market clinical services in the emerging markets of Central and Eastern Europe. Since then, POI has expanded its services to more than 40 countries, including: North America, Western Europe, Central & Eastern Europe, Latin America, India, and South Africa. Today, POI has one of the largest global footprints of any CRO. They are committed to establishing and maintaining the industry's strongest multi-national presence. Its monitors have the most extensive knowledge of local and regional customs and sites across a broad range of therapeutic areas. POI has an entirely different model than other CROs- they call it global decentralization. The success of this model has been proven time and again. | - |
Yamin Khan | M | 55 |
Pharm-Olam International Ltd.
Pharm-Olam International Ltd. Miscellaneous Commercial ServicesCommercial Services Pharm-Olam International started operations in 1994 with the premise of delivering cost effective, quick-to-market clinical services in the emerging markets of Central and Eastern Europe. Since then, POI has expanded its services to more than 40 countries, including: North America, Western Europe, Central & Eastern Europe, Latin America, India, and South Africa. Today, POI has one of the largest global footprints of any CRO. They are committed to establishing and maintaining the industry's strongest multi-national presence. Its monitors have the most extensive knowledge of local and regional customs and sites across a broad range of therapeutic areas. POI has an entirely different model than other CROs- they call it global decentralization. The success of this model has been proven time and again. | - |
John Sordillo | M | - |
Pharm-Olam LLC
Pharm-Olam LLC Miscellaneous Commercial ServicesCommercial Services Pharm-Olam LLC operates as a clinical research organization (CRO). It offers trial services to pharmaceutical, biotechnology, government, and public health organizations It specializes in small molecule therapies and biologics in oncology-hematology, rare disease, allergy, autoimmune, infectious disease, and vaccines. The company was founded by Zev Munk and Eugene Barg in 1994 and is headquartered in Houston, TX. | - |
Elizabeth Garner | M | 56 |
Pharm-Olam LLC
Pharm-Olam LLC Miscellaneous Commercial ServicesCommercial Services Pharm-Olam LLC operates as a clinical research organization (CRO). It offers trial services to pharmaceutical, biotechnology, government, and public health organizations It specializes in small molecule therapies and biologics in oncology-hematology, rare disease, allergy, autoimmune, infectious disease, and vaccines. The company was founded by Zev Munk and Eugene Barg in 1994 and is headquartered in Houston, TX. | - |
Anthony Orlando | M | - |
Pharm-Olam International Ltd.
Pharm-Olam International Ltd. Miscellaneous Commercial ServicesCommercial Services Pharm-Olam International started operations in 1994 with the premise of delivering cost effective, quick-to-market clinical services in the emerging markets of Central and Eastern Europe. Since then, POI has expanded its services to more than 40 countries, including: North America, Western Europe, Central & Eastern Europe, Latin America, India, and South Africa. Today, POI has one of the largest global footprints of any CRO. They are committed to establishing and maintaining the industry's strongest multi-national presence. Its monitors have the most extensive knowledge of local and regional customs and sites across a broad range of therapeutic areas. POI has an entirely different model than other CROs- they call it global decentralization. The success of this model has been proven time and again. | - |
Eric Rupprath | M | - |
Pharm-Olam International Ltd.
Pharm-Olam International Ltd. Miscellaneous Commercial ServicesCommercial Services Pharm-Olam International started operations in 1994 with the premise of delivering cost effective, quick-to-market clinical services in the emerging markets of Central and Eastern Europe. Since then, POI has expanded its services to more than 40 countries, including: North America, Western Europe, Central & Eastern Europe, Latin America, India, and South Africa. Today, POI has one of the largest global footprints of any CRO. They are committed to establishing and maintaining the industry's strongest multi-national presence. Its monitors have the most extensive knowledge of local and regional customs and sites across a broad range of therapeutic areas. POI has an entirely different model than other CROs- they call it global decentralization. The success of this model has been proven time and again. | - |
Matt Delaney | M | - |
Pharm-Olam International Ltd.
Pharm-Olam International Ltd. Miscellaneous Commercial ServicesCommercial Services Pharm-Olam International started operations in 1994 with the premise of delivering cost effective, quick-to-market clinical services in the emerging markets of Central and Eastern Europe. Since then, POI has expanded its services to more than 40 countries, including: North America, Western Europe, Central & Eastern Europe, Latin America, India, and South Africa. Today, POI has one of the largest global footprints of any CRO. They are committed to establishing and maintaining the industry's strongest multi-national presence. Its monitors have the most extensive knowledge of local and regional customs and sites across a broad range of therapeutic areas. POI has an entirely different model than other CROs- they call it global decentralization. The success of this model has been proven time and again. | - |
G. Stephen DeCherney | M | 71 |
Pharm-Olam LLC
Pharm-Olam LLC Miscellaneous Commercial ServicesCommercial Services Pharm-Olam LLC operates as a clinical research organization (CRO). It offers trial services to pharmaceutical, biotechnology, government, and public health organizations It specializes in small molecule therapies and biologics in oncology-hematology, rare disease, allergy, autoimmune, infectious disease, and vaccines. The company was founded by Zev Munk and Eugene Barg in 1994 and is headquartered in Houston, TX. | - |
Sean Alan F. X. Reade | M | - |
Pharm-Olam International Ltd.
Pharm-Olam International Ltd. Miscellaneous Commercial ServicesCommercial Services Pharm-Olam International started operations in 1994 with the premise of delivering cost effective, quick-to-market clinical services in the emerging markets of Central and Eastern Europe. Since then, POI has expanded its services to more than 40 countries, including: North America, Western Europe, Central & Eastern Europe, Latin America, India, and South Africa. Today, POI has one of the largest global footprints of any CRO. They are committed to establishing and maintaining the industry's strongest multi-national presence. Its monitors have the most extensive knowledge of local and regional customs and sites across a broad range of therapeutic areas. POI has an entirely different model than other CROs- they call it global decentralization. The success of this model has been proven time and again. | - |
Pavle Vukojevic | M | - |
Pharm-Olam International Ltd.
Pharm-Olam International Ltd. Miscellaneous Commercial ServicesCommercial Services Pharm-Olam International started operations in 1994 with the premise of delivering cost effective, quick-to-market clinical services in the emerging markets of Central and Eastern Europe. Since then, POI has expanded its services to more than 40 countries, including: North America, Western Europe, Central & Eastern Europe, Latin America, India, and South Africa. Today, POI has one of the largest global footprints of any CRO. They are committed to establishing and maintaining the industry's strongest multi-national presence. Its monitors have the most extensive knowledge of local and regional customs and sites across a broad range of therapeutic areas. POI has an entirely different model than other CROs- they call it global decentralization. The success of this model has been proven time and again. | 27 years |
Madeline Ducate | F | - |
Pharm-Olam International Ltd.
Pharm-Olam International Ltd. Miscellaneous Commercial ServicesCommercial Services Pharm-Olam International started operations in 1994 with the premise of delivering cost effective, quick-to-market clinical services in the emerging markets of Central and Eastern Europe. Since then, POI has expanded its services to more than 40 countries, including: North America, Western Europe, Central & Eastern Europe, Latin America, India, and South Africa. Today, POI has one of the largest global footprints of any CRO. They are committed to establishing and maintaining the industry's strongest multi-national presence. Its monitors have the most extensive knowledge of local and regional customs and sites across a broad range of therapeutic areas. POI has an entirely different model than other CROs- they call it global decentralization. The success of this model has been proven time and again. | - |
John Hovre | M | - |
Pharm-Olam International Ltd.
Pharm-Olam International Ltd. Miscellaneous Commercial ServicesCommercial Services Pharm-Olam International started operations in 1994 with the premise of delivering cost effective, quick-to-market clinical services in the emerging markets of Central and Eastern Europe. Since then, POI has expanded its services to more than 40 countries, including: North America, Western Europe, Central & Eastern Europe, Latin America, India, and South Africa. Today, POI has one of the largest global footprints of any CRO. They are committed to establishing and maintaining the industry's strongest multi-national presence. Its monitors have the most extensive knowledge of local and regional customs and sites across a broad range of therapeutic areas. POI has an entirely different model than other CROs- they call it global decentralization. The success of this model has been proven time and again. | 28 years |
Helen Springford | F | - |
Pharm-Olam International Ltd.
Pharm-Olam International Ltd. Miscellaneous Commercial ServicesCommercial Services Pharm-Olam International started operations in 1994 with the premise of delivering cost effective, quick-to-market clinical services in the emerging markets of Central and Eastern Europe. Since then, POI has expanded its services to more than 40 countries, including: North America, Western Europe, Central & Eastern Europe, Latin America, India, and South Africa. Today, POI has one of the largest global footprints of any CRO. They are committed to establishing and maintaining the industry's strongest multi-national presence. Its monitors have the most extensive knowledge of local and regional customs and sites across a broad range of therapeutic areas. POI has an entirely different model than other CROs- they call it global decentralization. The success of this model has been proven time and again. | 24 years |
Michael Cannizzaro | M | - |
Pharm-Olam LLC
Pharm-Olam LLC Miscellaneous Commercial ServicesCommercial Services Pharm-Olam LLC operates as a clinical research organization (CRO). It offers trial services to pharmaceutical, biotechnology, government, and public health organizations It specializes in small molecule therapies and biologics in oncology-hematology, rare disease, allergy, autoimmune, infectious disease, and vaccines. The company was founded by Zev Munk and Eugene Barg in 1994 and is headquartered in Houston, TX. | - |
David Murcar | M | - |
Pharm-Olam International Ltd.
Pharm-Olam International Ltd. Miscellaneous Commercial ServicesCommercial Services Pharm-Olam International started operations in 1994 with the premise of delivering cost effective, quick-to-market clinical services in the emerging markets of Central and Eastern Europe. Since then, POI has expanded its services to more than 40 countries, including: North America, Western Europe, Central & Eastern Europe, Latin America, India, and South Africa. Today, POI has one of the largest global footprints of any CRO. They are committed to establishing and maintaining the industry's strongest multi-national presence. Its monitors have the most extensive knowledge of local and regional customs and sites across a broad range of therapeutic areas. POI has an entirely different model than other CROs- they call it global decentralization. The success of this model has been proven time and again. | - |
Connections Chart
Multi-company connection
Statistics
Country | Connections | % of total |
---|---|---|
United States | 23 | 100.00% |
United Kingdom | 1 | 4.35% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Robert J. Davie
- Personal Network